» Articles » PMID: 34782859

Lipid and Fatty Acid Metabolism in Trypanosomatids

Overview
Journal Microb Cell
Specialty Microbiology
Date 2021 Nov 16
PMID 34782859
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Trypanosomiases and leishmaniases are neglected tropical diseases that have been spreading to previously non-affected areas in recent years. Identification of new chemotherapeutics is needed as there are no vaccines and the currently available treatment options are highly toxic and often ineffective. The causative agents for these diseases are the protozoan parasites of the Trypanosomatidae family, and they alternate between invertebrate and vertebrate hosts during their life cycles. Hence, these parasites must be able to adapt to different environments and compete with their hosts for several essential compounds, such as amino acids, vitamins, ions, carbohydrates, and lipids. Among these nutrients, lipids and fatty acids (FAs) are essential for parasite survival. Trypanosomatids require massive amounts of FAs, and they can either synthesize FAs or scavenge them from the host. Moreover, FAs are the major energy source during specific life cycle stages of , and . Therefore, considering the distinctive features of FAs metabolism in trypanosomatids, these pathways could be exploited for the development of novel antiparasitic drugs. In this review, we highlight specific aspects of lipid and FA metabolism in the protozoan parasites and spp., as well as the pathways that have been explored for the development of new chemotherapies.

Citing Articles

Exploring the activity of the putative Δ6-desaturase and its role in bloodstream form life-cycle transitions in Trypanosoma brucei.

Cerone M, Smith T PLoS Pathog. 2025; 21(2):e1012691.

PMID: 39965027 PMC: 11867338. DOI: 10.1371/journal.ppat.1012691.


Spiroplasma endosymbiont reduction of host lipid synthesis and Stomoxyn-like peptide contribute to trypanosome resistance in the tsetse fly Glossina fuscipes.

Awuoche E, Smallenberger G, Bruzzese D, Orfano A, Weiss B, Aksoy S PLoS Pathog. 2025; 21(1):e1012692.

PMID: 39888974 PMC: 11819587. DOI: 10.1371/journal.ppat.1012692.


Changes in lipid abundance are associated with disease progression and treatment response in chronic Trypanosoma cruzi infection.

Gabaldon-Figueira J, Ros-Lucas A, Martinez-Peinado N, Blackburn G, Losada-Galvan I, Posada E Parasit Vectors. 2024; 17(1):459.

PMID: 39521974 PMC: 11549750. DOI: 10.1186/s13071-024-06548-3.


endosymbiont reduction of host lipid synthesis and Stomoxyn-like peptide contribute to trypanosome resistance in the tsetse fly .

Awuoche E, Smallenberger G, Bruzzese D, Orfano A, Weiss B, Aksoy S bioRxiv. 2024; .

PMID: 39484388 PMC: 11527105. DOI: 10.1101/2024.10.24.620045.


Evolutionary divergent clusters of transcribed extinct truncated retroposons drive low mRNA expression and developmental regulation in the protozoan Leishmania.

Ferreira G, Emond-Rheault J, Alves L, Leprohon P, Smith M, Papadopoulou B BMC Biol. 2024; 22(1):249.

PMID: 39468514 PMC: 11520807. DOI: 10.1186/s12915-024-02051-4.


References
1.
Ralton J, McConville M . Delineation of three pathways of glycosylphosphatidylinositol biosynthesis in Leishmania mexicana. Precursors from different pathways are assembled on distinct pools of phosphatidylinositol and undergo fatty acid remodeling. J Biol Chem. 1998; 273(7):4245-57. DOI: 10.1074/jbc.273.7.4245. View

2.
Lee S, Stephens J, Englund P . A fatty-acid synthesis mechanism specialized for parasitism. Nat Rev Microbiol. 2007; 5(4):287-97. DOI: 10.1038/nrmicro1617. View

3.
Pereira M, Visbal G, Costa T, Frases S, De Souza W, Atella G . Trypanosoma cruzi epimastigotes store cholesteryl esters in lipid droplets after cholesterol endocytosis. Mol Biochem Parasitol. 2018; 224:6-16. DOI: 10.1016/j.molbiopara.2018.07.004. View

4.
Manne-Goehler J, Umeh C, Montgomery S, Wirtz V . Estimating the Burden of Chagas Disease in the United States. PLoS Negl Trop Dis. 2016; 10(11):e0005033. PMC: 5098725. DOI: 10.1371/journal.pntd.0005033. View

5.
Merrill Jr A . Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem Rev. 2011; 111(10):6387-422. PMC: 3191729. DOI: 10.1021/cr2002917. View